Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 5,499	$ 8,077
Short-term investments	1,751	3
Accounts receivable, less allowances of $197 and $193	7,931	8,221
Inventories	5,133	5,088
Contract assets, net	1,422	1,443
Other current assets	1,904	1,757
Total current assets	23,640	24,589
Property, plant and equipment, net	9,324	9,448
Acquisition-related intangible assets, net	16,048	16,670
Other assets	4,241	3,999
Goodwill	43,843	44,020
Total assets	97,095	98,726
Current liabilities:
Short-term obligations and current maturities of long-term obligations	4,451	3,609
Accounts payable	2,555	2,872
Accrued payroll and employee benefits	1,314	1,596
Contract liabilities	2,632	2,689
Other accrued expenses	2,985	3,246
Total current liabilities	13,937	14,012
Deferred income taxes	1,811	1,922
Other long-term liabilities	4,567	4,642
Long-term obligations	31,157	31,308
Redeemable noncontrolling interest	119	118
Thermo Fisher Scientific Inc. shareholders’ equity:
Total Liabilities	51472.0	51884.0	0	0	0
Preferred stock, $100 par value, 50,000 shares authorized; none issued	0	0
Common stock, $1 par value, 1,200,000,000 shares authorized; 442,822,699 and 442,188,634 shares issued	443	442
Capital in excess of par value	17,482	17,286
Retained earnings	48,542	47,364
Treasury stock at cost, 61,106,376 and 55,541,290 shares	(18,186)	(15,133)
Accumulated other comprehensive income/(loss)	(2,764)	(3,224)
Total Thermo Fisher Scientific Inc. shareholders’ equity	45,516	46,735
Noncontrolling interests	(12)	(11)
Total equity	45,504	46,724
Total liabilities, redeemable noncontrolling interest and equity	$ 97,095	$ 98,726

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481990/310-10-45-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481990/310-10-45-9